Immunoassay Analyzer Test


SkyHighTech

Uploaded on Apr 16, 2022

MeMed BV is the only test for distinguishing bacterial from viral infections that has been validated in multinational, double-blind and external clinical studies. The clinical studies demonstrating the diagnostic performance of MeMed BV encompassed thousands of patients and are published in high impact medical journals.

Comments

                     

Immunoassay Analyzer Test

Immunoassay Analyzer Test The immunoassay analyzer test is a blood test that measures the amount of protein in your blood. Proteins are one of the body's main building blocks. They include hormones, antibodies and enzymes. Have symptoms that suggest a hormone imbalance or condition associated with a certain protein, such as Cushing's syndrome or polycystic ovary syndrome (PCOS) Know More- Immunoassay Analyzer Test Are being monitored for response to treatment for a condition associated with a specific protein, such as thyroid disorder or cancer The immunoassay analyzer is a high-tech product employing the modern biotechnology and microelectronics technology, which is a new generation of fully automated blood chemistry analyzer, using electrochemiluminescence method to achieve the determination of serum and plasma. Based on the strong R & D ability and rich practical experience in medical engineering field for many years, our company was able to develop this product independently after three years of hard work. It has been approved by clinical experts and doctors in many aspects, such as performance, stability, ease of use and reliability. The immunoassay analyzer is mainly used to determine the amount of free hormone or free drug in serum and plasma. It can be widely used in biochemical laboratories in hospitals and scientific research institutes to analyze hormones, therapeutic drugs, vitamins, tumor markers, etc. The term "immunoassay" is a play on words, meaning assay ("to analyze") using an antigen-antibody reaction. The use of immunoassays as diagnostic and analytical tools have become more widespread due to the availability of monoclonal antibodies, which have made the development of homogeneous immunoassays possible, and to the automation of the analytical process. A sensitive and specific immunoassay for the detection of estrogen receptor (ER) beta in breast cancer cell lines and tissue extracts was developed. A monoclonal antibody, 7B10, was used to detect ER beta, a novel estrogen-regulated gene expressed in human breast cancer cells with high affinity for estradiol (E2). Using this antibody, ER beta was specifically detected using immunoprecipitation and immunoblotting.